Continuous function of 80 primary renal allografts for 30–47 years with maintenance prednisone and azathioprine/mycophenolate mofetil therapy: A clinical mosaic of long‐term successes
暂无分享,去创建一个
W. Baldwin | J. Schold | J. Nally | W. Braun | R. Fairchild | R. Avery | E. Poggio | L. Herlitz | D. Goldfarb | S. Nakamoto | B. Stephany | Jianbo Li | J. Augustine | R. Fatica | J. W. Tomford | K. Brown | W. Kiser | W. Braun
[1] A. Dispenzieri,et al. Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications. , 2018, Blood.
[2] B. Nieswandt,et al. Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration , 2018, Proceedings of the National Academy of Sciences.
[3] M. Stegall,et al. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] J. Cerhan,et al. Long‐Term Follow‐up of Monoclonal Gammopathy of Undetermined Significance , 2018, The New England journal of medicine.
[5] S. Nasr,et al. Dysproteinemias and Glomerular Disease. , 2018, Clinical journal of the American Society of Nephrology : CJASN.
[6] A. Israni,et al. OPTN/SRTR 2016 Annual Data Report: Kidney , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[7] M. Luppi,et al. Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience , 2017, Transplantation.
[8] J. Friedewald,et al. B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[9] G. Nadkarni,et al. Analysis of OPTN/UNOS registry suggests the number of HLA matches and not mismatches is a stronger independent predictor of kidney transplant survival. , 2017, Kidney international.
[10] S. Fuggle,et al. Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study , 2016, Transplantation direct.
[11] Graham M Lord,et al. Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment? , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[12] P. Grimbert,et al. Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant. , 2016, Journal of the American Society of Nephrology : JASN.
[13] A. Kirk,et al. Longitudinal Studies of a B Cell–Derived Signature of Tolerance in Renal Transplant Recipients , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] S. Navaneethan,et al. Cause-Specific Deaths in Non-Dialysis-Dependent CKD. , 2015, Journal of the American Society of Nephrology : JASN.
[15] A. Dispenzieri,et al. Diagnosis of monoclonal gammopathy of renal significance. , 2015, Kidney international.
[16] W. Baldwin,et al. Platelets in early antibody-mediated rejection of renal transplants. , 2015, Journal of the American Society of Nephrology : JASN.
[17] M. Tonelli,et al. Cause of Death in Patients with Reduced Kidney Function. , 2015, Journal of the American Society of Nephrology : JASN.
[18] A. Courtney,et al. The Clinical Course of Kidney Transplant Recipients After 20 Years of Graft Function , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[19] B. Ho-Tin-Noé,et al. Platelets in Inflammation: Regulation of Leukocyte Activities and Vascular Repair , 2014, Front. Immunol..
[20] C. Acosta,et al. Comparative analysis of drug action on B-cell proliferation and differentiation for mycophenolic acid, everolimus, and prednisolone. , 2014 .
[21] S. Benlloch,et al. Gene expression signature of tolerance and lymphocyte subsets in stable renal transplants: results of a cross-sectional study. , 2014, Transplant immunology.
[22] S. Brouard,et al. Biomarkers and possible mechanisms of operational tolerance in kidney transplant patients , 2014, Immunological reviews.
[23] K. Iwasaki,et al. Comparative Analysis of Drug Action on B-Cell Proliferation and Differentiation for Mycophenolic Acid, Everolimus, and Prednisolone , 2014, Transplantation.
[24] A. Kalil,et al. What Is the Impact of Hypogammaglobulinemia on the Rate of Infections and Survival in Solid Organ Transplantation? A Meta‐Analysis , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[25] M. Denton,et al. Twenty‐Year Survivors of Kidney Transplantation , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[26] F. Bemelman,et al. The Natural History of Clinical Operational Tolerance After Kidney Transplantation Through Twenty‐Seven Cases , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[27] E. Decullier,et al. Sirolimus and secondary skin-cancer prevention in kidney transplantation. , 2012, The New England journal of medicine.
[28] T. Wynn,et al. Mechanisms of fibrosis: therapeutic translation for fibrotic disease , 2012, Nature Medicine.
[29] N. Pallet,et al. Clinical and immunological features of very long‐term survivors with a single renal transplant , 2012, Transplant international : official journal of the European Society for Organ Transplantation.
[30] L. French,et al. Reversal of UVA Skin Photosensitivity and DNA Damage in Kidney Transplant Recipients by Replacing Azathioprine , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[31] J. E. Murray,et al. Edith Helm (April 29, 1935–April 4, 2011): The World's Longest Surviving Transplant Recipient , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[32] K. Lamb,et al. Long‐Term Renal Allograft Survival in the United States: A Critical Reappraisal , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[33] R. Bataille,et al. Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. , 2010, Kidney international.
[34] Graham M Lord,et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. , 2010, The Journal of clinical investigation.
[35] M. Suthanthiran,et al. Identification of a B cell signature associated with renal transplant tolerance in humans. , 2010, The Journal of clinical investigation.
[36] Ethan M Balk,et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. , 2010, Kidney international.
[37] K. Saeb‐Parsy,et al. Antiplatelet therapy in transplantation: new tricks from old drugs? , 2009, Transplantation.
[38] M. Weyand,et al. Attenuation of Transplant Arteriosclerosis With Clopidogrel Is Associated With a Reduction of Infiltrating Dendritic Cells and Macrophages in Murine Aortic Allografts , 2009, Transplantation.
[39] A. Matas,et al. 2202 Kidney Transplant Recipients with 10 Years of Graft Function: What Happens Next? , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[40] P. Terasaki,et al. Escape from sensitization to HL-A antibodies. , 2008, Tissue antigens.
[41] E. Woodle,et al. A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy , 2008, Annals of surgery.
[42] S. Pitchford. Novel uses for anti‐platelet agents as anti‐inflammatory drugs , 2007, British journal of pharmacology.
[43] D. Kaufman,et al. Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[44] J. Curtis. Corticosteroids and kidney transplantation. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[45] J. Myles,et al. Ultra‐Late Antibody‐Mediated Rejection 30 Years After a Living‐Related Renal Allograft , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[46] B. Kasiske,et al. Prednisone‐Free Maintenance Immunosuppression—A 5‐Year Experience , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[47] O. Pankewycz,et al. Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety. , 2005, Surgery.
[48] B. Kasiske,et al. Cancer after Kidney Transplantation in the United States , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[49] J. Schold,et al. Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[50] P. Fraker,et al. Glucocorticoid-Induced Apoptosis in Early B Cells from Human Bone Marrow , 2002, Experimental biology and medicine.
[51] R. Colvin,et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. , 2002, Journal of the American Society of Nephrology : JASN.
[52] K. Salmela,et al. Renal transplant recipients with graft survival longer than 20 years: report on 107 cases. , 2001, Transplantation proceedings.
[53] R. Colvin,et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. , 2001, Journal of the American Society of Nephrology : JASN.
[54] D. Stablein,et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group. , 1999, Transplantation.
[55] W. Braun,et al. Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years. , 1999, Transplantation.
[56] J. Alexander,et al. Characteristics of long-term renal transplant survivors. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[57] R. Rubin,et al. Infection in organ-transplant recipients. , 1998, The New England journal of medicine.
[58] W. Braun,et al. Life after 20 years with a kidney transplant: redefined disease profiles and an emerging nondiabetic vasculopathy. , 1997, Transplantation proceedings.
[59] Santa Jeremy Ono,et al. Modulation of MHC class II expression in human cells by dexamethasone. , 1995, Cellular immunology.
[60] A. King,et al. Status of long-term (25 years) survival of kidney transplant patients. , 1993, Transplantation proceedings.
[61] D. Maki,et al. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis , 1990, Pediatric Nephrology.
[62] I. Cohen,et al. Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins. , 1989, The Journal of clinical investigation.
[63] A. Fauci,et al. Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation. , 1985, The Journal of clinical investigation.
[64] J. Thompson,et al. Sudden death following high-dose intravenous methylprednisolone. , 1983, Transplantation.
[65] M. Sporn,et al. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. , 1983, The Journal of biological chemistry.
[66] A. Matas,et al. Seven Years' Experience with Antilymphoblast Globulin for Renal Transplantation From Cadaver Donors , 1976, Annals of surgery.
[67] Whittier Fc,et al. Sudden death after bolus steroid therapy for acute rejection. , 1976 .
[68] W. Braun,et al. Microangiopathic hemolytic anemia in renal allotransplantation: Report of a successfully treated case and review of the literature , 1975 .
[69] J. Salaman,et al. Methyl prednisolone in the treatment of renal transplant rejection. , 1974, Clinical nephrology.
[70] E. W. Carpenter,et al. Rejection crises in human renal transplant recipients: control with high dose methylprednisolone therapy. , 1972, Archives of surgery.
[71] W. Braun,et al. HUMAN RENAL ALLOGRAFTS: The Role of Vascular Injury in Early Graft Failure , 1971, Medicine.
[72] P. Kincaid‐smith,et al. Modification of the vascular lesions of rejection in cadaveric renal allografts by dipyridamole and anticoagulants. , 1969, Lancet.
[73] E. Reynolds,et al. HUMAN RENAL ISOGRAFTS: A CLINICAL AND PATHOLOGIC ANALYSIS1 , 1968 .
[74] W. Kolff,et al. RENAL HOMOTRANSPLANTATION IN MAN; REPORT OF SIX CONSECUTIVE CASES. , 1964, Annals of internal medicine.
[75] R. Wilson,et al. Successful transplantation of kidney from a human cadaver. , 1963, JAMA.
[76] J. H. Harrison,et al. Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. , 1963, Annals of plastic surgery.
[77] J. H. Harrison,et al. Surgical management of fifty patients with kidney transplants including eighteen pairs of twins. , 1963, American journal of surgery.
[78] A. Sadri,et al. : A Single-Center Experience , 2020 .
[79] T. Starzl,et al. Fifty years later. , 2013, Clinical transplants.
[80] S. Navaneethan,et al. World-Wide Long-Term (20–40 Years) Renal Transplant Outcomes and Classification of Long-Term Patient and Allograft Survivals , 2011 .
[81] Kuroiwa,et al. Report of a Successfully Treated Case , 2006 .
[82] B. Kasiske,et al. Long-term results and complications of renal transplantation: the Hennepin experience. , 1997, Clinical transplants.
[83] F. Whittier,et al. Sudden death after bolus steroid therapy for acute rejection. , 1976, Transplantation proceedings.
[84] A. Carter. Letter: Pyridoxine contraindicated in parkinsonism. , 1973, Lancet.
[85] K. Tung,et al. Immunosuppression with antilymphocyte globulin in clinical renal transplantation. , 1968, Surgical forum.
[86] J. H. Harrison,et al. Renal homotransplantation in identical twins. , 1956, Surgical forum.